As the world navigates the coronavirus disease 2019 (COVID-19) pandemic, there is a
growing need to assess its impact in patients with autoimmune rheumatic diseases, such as …

Patients with systemic lupus erythematosus (SLE) form a vulnerable group in terms of the
impact of the COVID-19 pandemic on disease management. We conducted this overview by …

The objectives of the study were to review the articles to identify (a) the epidemiology of
systemic lupus erythematosus (SLE) and coronavirus disease 2019 (COVID-19);(b) the …

(1) Background and Objectives: The COVID-19 pandemic influenced the management of
patients with immune-mediated rheumatic and musculoskeletal diseases (imRMDs) in …

Little is known about the impact of coronavirus disease 2019 (COVID-19) pandemic to the
care of patients with systemic lupus erythematosus (SLE) in the long-term. By crossing …

Introduction Patients with systemic lupus erythematous were vulnerable to severe
coronavirus disease 2019 infection and the negative impact of disrupted healthcare delivery …

Systemic lupus erythematosus (SLE) is a more common autoimmune rheumatic disease in
the Asia‐Pacific region. The prognosis of SLE remains unsatisfactory in some Asian …

Background To determine the impact of health care interruption (HCI), on clinical status of
the patients reincorporated to an outpatient clinic for rheumatic diseases (OCDIR), from a …

Objectives Public health emergencies (PHE) can disrupt personal medication practices and
increase the risk of medication-related harm and other negative medication-related …

A pandemic caused by the novel coronavirus (COVID‐19) is causing an unprecedented
situation for the world's health services. Health, local communities, and government are …